Hot signal

Submit
Hot signal
BAMPTD insists on removing regulatory constraints for parallel import

BAMPTD insists on removing regulatory constraints for parallel import

Sofia, September 18 / Desislava Peeva, BTA /

The Bulgarian Association for Medicines Parallel Trade Development insists on changing the regulatory framework and removing constraints. This...

Casper Ernst: Parallel imports are part of the decision on access to medicines

Casper Ernst: Parallel imports are part of the decision on access to medicines

Tuesday, 18 September 2018 | 17:30:40 Nadezhda Nenova

The challenges to the drug market are two. One is for the patient to be able to afford it, and the other is the shortage....

Legislative changes to the parallel drug trade have demanded from BAMPTD

Legislative changes to the parallel drug trade have demanded from BAMPTD

Tuesday, 18 September 2018 | 17:30:40 Nadezhda Nenova

Amendments to the Law on Medicinal Products in Human Medicine and the Ordinance on the Conditions, Rules and Procedure for Regulation...

Half a billion euro a year saves Europe from parallel imports, Bulgaria is lagging behind due to regulatory obstacles

Half a billion euro a year saves Europe from parallel imports, Bulgaria is lagging behind due to regulatory obstacles

Parallel imports create competition on the drug market with a price effect benefitting patients and a quick solution to overcoming shortages. This became clear at a Round table dedicated to...

Drugs import is the solution for 53% of the shortage reports shows the first interim BAMPTD Internet platform results

Drugs import is the solution for 53% of the shortage reports shows the first interim BAMPTD Internet platform results

182 signals from the whole country were received and processed on Bulgarian Association for Medicines Parallel...